Literature DB >> 33950562

O-GlcNAc Engineering on a Target Protein in Cells with Nanobody-OGT and Nanobody-splitOGA.

Daniel H Ramirez1, Yun Ge1, Christina M Woo1.   

Abstract

The monosaccharide O-linked N-acetyl glucosamine (O-GlcNAc) is an essential and dynamic post-translational modification (PTM) that decorates thousands of nucleocytoplasmic proteins. Interrogating the role of O-GlcNAc on a target protein is crucial yet challenging to perform in cells. We recently reported a pair of methods to selectively install or remove O-GlcNAc on a target protein in cells using an engineered O-GlcNAc transferase (OGT) or split O-GlcNAcase (OGA) fused to a nanobody. Target protein O-GlcNAcylation and de-O-GlcNAcylation complements methods to interrogate the role of O-GlcNAc on a global scale or at individual glycosites. Herein, we describe a protocol for utilizing the nanobody-OGT and nanobody-splitOGA systems to screen for O-GlcNAc functionality on a target protein. We additionally include associated protocols for the detection of O-GlcNAc and cloning procedures to adapt the method for the user's target protein of interest.
© 2021 Wiley Periodicals LLC. Basic Protocol 1: Target protein O-GlcNAcylation of JunB using nanobody-OGT Basic Protocol 2: Target protein deglycosylation of Nup62 using nanobody-splitOGA Alternate Protocol: Verification of the O-GlcNAc state of a tagged target protein through chemoenzymatic labeling Support Protocol: Cloning of new nanobody-OGT/nanobody-splitOGA and target protein pairs. © 2021 Wiley Periodicals LLC.

Entities:  

Keywords:  O-GlcNAc; deglycosylation; glycosylation; nanobodies; post-translational modification; proximity-direction

Mesh:

Substances:

Year:  2021        PMID: 33950562      PMCID: PMC8162732          DOI: 10.1002/cpz1.117

Source DB:  PubMed          Journal:  Curr Protoc        ISSN: 2691-1299


  27 in total

1.  Structure and properties of a complex of α-synuclein and a single-domain camelid antibody.

Authors:  Erwin J De Genst; Tim Guilliams; Joke Wellens; Elizabeth M O'Day; Christopher A Waudby; Sarah Meehan; Mireille Dumoulin; Shang-Te Danny Hsu; Nunilo Cremades; Koen H G Verschueren; Els Pardon; Lode Wyns; Jan Steyaert; John Christodoulou; Christopher M Dobson
Journal:  J Mol Biol       Date:  2010-07-08       Impact factor: 5.469

Review 2.  The utility of ETD mass spectrometry in proteomic analysis.

Authors:  Leann M Mikesh; Beatrix Ueberheide; An Chi; Joshua J Coon; John E P Syka; Jeffrey Shabanowitz; Donald F Hunt
Journal:  Biochim Biophys Acta       Date:  2006-10-30

3.  Optogenetic activation of intracellular antibodies for direct modulation of endogenous proteins.

Authors:  Daseuli Yu; Hansol Lee; Jongryul Hong; Hyunjin Jung; YoungJu Jo; Byung-Ha Oh; Byung Ouk Park; Won Do Heo
Journal:  Nat Methods       Date:  2019-10-14       Impact factor: 28.547

4.  Modulation of protein properties in living cells using nanobodies.

Authors:  Axel Kirchhofer; Jonas Helma; Katrin Schmidthals; Carina Frauer; Sheng Cui; Annette Karcher; Mireille Pellis; Serge Muyldermans; Corella S Casas-Delucchi; M Cristina Cardoso; Heinrich Leonhardt; Karl-Peter Hopfner; Ulrich Rothbauer
Journal:  Nat Struct Mol Biol       Date:  2009-12-13       Impact factor: 15.369

5.  A potent mechanism-inspired O-GlcNAcase inhibitor that blocks phosphorylation of tau in vivo.

Authors:  Scott A Yuzwa; Matthew S Macauley; Julia E Heinonen; Xiaoyang Shan; Rebecca J Dennis; Yuan He; Garrett E Whitworth; Keith A Stubbs; Ernest J McEachern; Gideon J Davies; David J Vocadlo
Journal:  Nat Chem Biol       Date:  2008-06-29       Impact factor: 15.040

6.  Recombinant probes for visualizing endogenous synaptic proteins in living neurons.

Authors:  Garrett G Gross; Jason A Junge; Rudy J Mora; Hyung-Bae Kwon; C Anders Olson; Terry T Takahashi; Emily R Liman; Graham C R Ellis-Davies; Aaron W McGee; Bernardo L Sabatini; Richard W Roberts; Don B Arnold
Journal:  Neuron       Date:  2013-06-19       Impact factor: 17.173

7.  Structure-Based Evolution of Low Nanomolar O-GlcNAc Transferase Inhibitors.

Authors:  Sara E S Martin; Zhi-Wei Tan; Harri M Itkonen; Damien Y Duveau; Joao A Paulo; John Janetzko; Paul L Boutz; Lisa Törk; Frederick A Moss; Craig J Thomas; Steven P Gygi; Michael B Lazarus; Suzanne Walker
Journal:  J Am Chem Soc       Date:  2018-10-04       Impact factor: 15.419

8.  Quantification of O-glycosylation stoichiometry and dynamics using resolvable mass tags.

Authors:  Jessica E Rexach; Claude J Rogers; Seok-Ho Yu; Jifang Tao; Yi E Sun; Linda C Hsieh-Wilson
Journal:  Nat Chem Biol       Date:  2010-07-25       Impact factor: 15.040

9.  A robust pipeline for rapid production of versatile nanobody repertoires.

Authors:  Peter C Fridy; Yinyin Li; Sarah Keegan; Mary K Thompson; Ilona Nudelman; Johannes F Scheid; Marlene Oeffinger; Michel C Nussenzweig; David Fenyö; Brian T Chait; Michael P Rout
Journal:  Nat Methods       Date:  2014-11-02       Impact factor: 28.547

10.  Detection and manipulation of live antigen-expressing cells using conditionally stable nanobodies.

Authors:  Jonathan Cy Tang; Eugene Drokhlyansky; Behzad Etemad; Stephanie Rudolph; Binggege Guo; Sui Wang; Emily G Ellis; Jonathan Z Li; Constance L Cepko
Journal:  Elife       Date:  2016-05-20       Impact factor: 8.140

View more
  3 in total

Review 1.  Methods for Studying Site-Specific O-GlcNAc Modifications: Successes, Limitations, and Important Future Goals.

Authors:  Stuart P Moon; Afraah Javed; Eldon R Hard; Matthew R Pratt
Journal:  JACS Au       Date:  2021-12-15

Review 2.  O-GlcNAcylation: an important post-translational modification and a potential therapeutic target for cancer therapy.

Authors:  Qingsong Lu; Xiaozhen Zhang; Tingbo Liang; Xueli Bai
Journal:  Mol Med       Date:  2022-09-14       Impact factor: 6.376

Review 3.  Targeting O-GlcNAcylation to overcome resistance to anti-cancer therapies.

Authors:  Ninon Very; Ikram El Yazidi-Belkoura
Journal:  Front Oncol       Date:  2022-08-17       Impact factor: 5.738

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.